about
Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.MRSA--what is it, and how do we deal with the problem?Review of current literature on the economic burden of Clostridium difficile infection.Ubiquitous Acinetobacter species as beneficial commensals but gradually being emboldened with antibiotic resistance genes.Plasmids and evolutionary rescue by drug resistance.ATLAS trials: efficacy and safety of telavancin compared with vancomycin for the treatment of skin infections.Clinico-microbiological study of Pseudomonas aeruginosa in wound infections and the detection of metallo-β-lactamase production.Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.The impact of pricing and patent expiration on demand for pharmaceuticals: an examination of the use of broad-spectrum antimicrobials.Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 1: Prevalence of antimicrobial-resistant Escherichia coli and methicillin-resistant Staphylococcus aureus.Serious antimicrobial resistance status of pathogens causing hospital-acquired lower respiratory tract infections in North China.Economic consequences of the demography of MRSA patients and the impact of broad-spectrum antimicrobials.How effective and cost-effective are behaviour change interventions in improving the prescription and use of antibiotics in low-income and middle-income countries? A protocol for a systematic review.
P2860
Q33935336-CA3C4B52-D4D3-4014-B109-36853660225BQ36150828-1B59CC21-1B81-4ACD-8E20-32DA8B579B93Q37339205-C322F34E-5C96-4C17-BB45-96DFE1A26C6CQ37987483-75E5D900-A5D1-4DC8-82E4-1714AE583A98Q39206654-536152A6-BE51-4B6F-9B94-D97CFBDC9402Q39816590-40F6FF17-8A00-41F3-B65E-6385DC55F3F5Q40931739-884D3181-F6E9-4761-9CFB-13A99D9AB4FFQ42637997-1E6638AA-3E37-4460-9421-5917F9EBE2A7Q44326553-40DEE184-72FB-4831-A8B4-89435039AFBCQ45198400-AFD0D59A-5B78-4367-9E1A-872D1200EF79Q45934005-F2D92DA0-76A3-4271-A354-80747DC17D7BQ47735948-C630EB05-3703-4DCA-A7CE-A1441AC9EC0CQ55091201-16CB577F-B804-4642-A5F4-5E62B0910DD8
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Economic consequences of antimicrobial resistance.
@ast
Economic consequences of antimicrobial resistance.
@en
type
label
Economic consequences of antimicrobial resistance.
@ast
Economic consequences of antimicrobial resistance.
@en
prefLabel
Economic consequences of antimicrobial resistance.
@ast
Economic consequences of antimicrobial resistance.
@en
P2093
P1433
P1476
Economic consequences of antimicrobial resistance.
@en
P2093
Connie S Price
Jenna L Sunderlin
Jerome J Schentag
Joseph A Paladino
P304
P356
10.1089/109629602761624225
P577
2002-01-01T00:00:00Z